124 related articles for article (PubMed ID: 10470128)
21. Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank.
Pluta K; Jeleń M; Morak-Młodawska B; Zimecki M; Artym J; Kocieba M
Pharmacol Rep; 2010; 62(2):319-32. PubMed ID: 20508288
[TBL] [Abstract][Full Text] [Related]
22. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
Zhukova OS; Dobrynin IaV
Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and antitumor cytotoxicity of novel bis-benzimidazoles.
Singh AK; Lown JW
Anticancer Drug Des; 2000 Aug; 15(4):265-75. PubMed ID: 11200502
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
[TBL] [Abstract][Full Text] [Related]
25. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
Marx KA; O'Neil P; Hoffman P; Ujwal ML
J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
[TBL] [Abstract][Full Text] [Related]
26. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
[TBL] [Abstract][Full Text] [Related]
27. The effect of a lectin from the venom of the snake, Bothrops jararacussu, on tumor cell proliferation.
Pereira-Bittencourt M; Carvalho DD; Gagliardi AR; Collins DC
Anticancer Res; 1999; 19(5B):4023-5. PubMed ID: 10628348
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity.
Doillon CJ; Gagnon E; Paradis R; Koutsilieris M
Anticancer Res; 2004; 24(4):2169-77. PubMed ID: 15330157
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
30. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G
Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292
[TBL] [Abstract][Full Text] [Related]
31. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
32. 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.
Bradshaw TD; Wrigley S; Shi DF; Schultz RJ; Paull KD; Stevens MF
Br J Cancer; 1998 Mar; 77(5):745-52. PubMed ID: 9514053
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes.
Chávez IO; Apan TR; Martínez-Vázquez M
J Pharm Pharmacol; 2005 Sep; 57(9):1087-91. PubMed ID: 16105229
[TBL] [Abstract][Full Text] [Related]
34. Diverse biological activities displayed by phenothiazines, benzo[a]phenothiazines and benz[c]acridins (review).
Molnár J; Sakagami H; Motohashi N
Anticancer Res; 1993; 13(4):1019-25. PubMed ID: 8352520
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer.
Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
[TBL] [Abstract][Full Text] [Related]
37. Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo.
Stankova J; Shang J; Rozen R
Clin Cancer Res; 2005 Mar; 11(5):2047-52. PubMed ID: 15756031
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as potential antitumor agents.
Vázquez MT; Romero M; Pujol MD
Bioorg Med Chem; 2004 Mar; 12(5):949-56. PubMed ID: 14980607
[TBL] [Abstract][Full Text] [Related]
39. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
Culhane AC; Perrière G; Higgins DG
BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
[TBL] [Abstract][Full Text] [Related]
40. The hollow fiber assay: continued characterization with novel approaches.
Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
